Lumena Pharmaceuticals

Manufacturing · California, United States · 501-1,000 Employees

View Company Info for Free

Overview

Headquarters

12531 High Bluff Dr Ste 110, San Diego, ...

Phone Number

(858) 461-0694

Revenue

$29.3 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Lumena Pharmaceuticals

Lumena Pharmaceuticals is dedicated to enhancing human health and longevity through innovative biomedical design. The company specializes in research and development, contract R&D, product development, and offers a range of services including pharmaceuticals, private label services, generics, and nutraceuticals. Their expertise lies in addressing the evolving needs of the home health market, particularly in areas such as aging, metabolism, gene therapy, and immunology. Lumena Pharmaceuticals seeks to attract passionate individuals to join their team in building a platform for future health advancements.Explore more
Lumena Pharmaceuticals's Social MediaPopular SearchesLumena Pharmaceuticals IncLumena PharmaceuticalsSIC Code 28,283NAICS Code 32,325Show more

Is Lumena Pharmaceuticals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Lumena Pharmaceuticals

Compare insights from companies similar to Lumena Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Lumena Pharmaceuticals

$29.3M
501-1,000
Private
$68M
2011
N/A
$1.6B
1K - 5K
Public
$251.2M
1987
Craig Hopkinson, Executive Vice President & Chief Marketing Officer, Research & Development at Alkermes
Craig HopkinsonExecutive Vice President & Chief Marketing Officer, Research & Development
$247.1M
51-200
Private
$293.1M
1996
$32.5M
501-1,000
Private
$288M
2015
$28.1M
51-200
Private
$221.6M
2008
DW
Daniel WagnerVice President, R & D Operations
$17.4M
51-200
Private
-
2000
AK
Alex KimDirector
$13.2M
51-200
Public
$214.1M
2012
JX
James XueChairman, President & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Lumena Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Lumena Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lumena Pharmaceuticals.

Lumena Pharmaceuticals financials insights

Gather financial insights about Lumena Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2013

Series A

$23M

2014

Series B

$45M

See All Lumena Pharmaceuticals's Financials Insights

Lumena Pharmaceuticals Tech Stack

Top Manufacturing Companies

Frequently Asked Questions Regarding Lumena Pharmaceuticals

What is Lumena Pharmaceuticals's official website?
Lumena Pharmaceuticals's official website is www.lumenapharma.com
What is Lumena Pharmaceuticals's Revenue?
Lumena Pharmaceuticals's revenue is $29.3 Million
What is Lumena Pharmaceuticals's SIC code?
Lumena Pharmaceuticals's SIC: 28,283
What is Lumena Pharmaceuticals's NAICS code?
Lumena Pharmaceuticals's NAICS: 32,325
How many employees does Lumena Pharmaceuticals have?
Lumena Pharmaceuticals has 501-1,000 employees
What industry does Lumena Pharmaceuticals belong to?
Lumena Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Lumena Pharmaceuticals competition?
Lumena Pharmaceuticals top competitors include: InnoCare Pharma, CANbridge Pharmaceuticals, ZS Pharma, Sucampo Pharmaceuticals
What companies has Lumena Pharmaceuticals acquired?
Lumena Pharmaceuticals has acquired the companies: ARIAD Pharmaceuticals, Cambridge Discovery Chemistry, Shire Pharmaceuticals, Nycomed
What technology does Lumena Pharmaceuticals use?
Some of the popular technologies that Lumena Pharmaceuticals uses are: Microsoft 365, GoDaddy DNS, Microsoft Dynamics 365 Business Central, Microsoft Exchange Online
How do I contact Lumena Pharmaceuticals?
Lumena Pharmaceuticals contact info: Phone number: (858) 461-0694 Website: www.lumenapharma.com
What does Lumena Pharmaceuticals do?

Lumena Pharmaceuticals is dedicated to enhancing human health and longevity through innovative biomedical design. The company specializes in research and development, contract R&D, product development, and offers a range of services including pharmaceuticals, private label services, generics, and nutraceuticals. Their expertise lies in addressing t... he evolving needs of the home health market, particularly in areas such as aging, metabolism, gene therapy, and immunology. Lumena Pharmaceuticals seeks to attract passionate individuals to join their team in building a platform for future health advancements.Read More

What are Lumena Pharmaceuticals social media links?
Lumena Pharmaceuticals Linkedin page Lumena Pharmaceuticals Twitter page
Who invested in Lumena Pharmaceuticals?
Lumena Pharmaceuticals has 9 investors including RA Capital Management, Pappas Capital, Alta Partners and RiverVest Venture Partners.
Is Lumena Pharmaceuticals a public company?
Lumena Pharmaceuticals is private company therefore does not currently have an official ticker symbol
See more information about Lumena Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.